The most valuable pharmaceutical brand TOP25, 2 Chinese companies on the list!

In the past few months, pharmaceutical and biotechnology companies have become the focus. Dozens of companies around the world are developing drugs and vaccines against COVID-19. In fact, the share prices of some pharmaceutical companies have doubled in just a few months. Fan.

However, not all companies in the pharmaceutical industry have a very valuable brand. Which pharmaceutical companies' brands have entered the relevant ranking list this year. Today I share with you a top 25 pharmaceutical brand.

Friends who follow MRCLUB should note that British brand consulting companies evaluate more than 5,000 global brands every year. The following ranking is Brand Finance's list of the top 25 pharmaceutical brands this year.

The top-ranked Johnson & Johnson company has seen its brand value drop by 11% since last year, but according to Richard Haigh, Managing Director of Brand Finance, Johnson & Johnson is expected to maintain its leading position in the industry in the next few years, thanks to the company’s research and development In terms of continuous investment, the company's latest investment is the development of a covid-19 vaccine.

Roche continued to grow, with a 10% growth rate last year to bring the brand value to 7.6 billion US dollars, ranking second in the list.

It is also worth mentioning that in addition to determining the overall brand value, Brand Finance also uses a balanced scorecard to assess the relative strength of the brand from three indicators: market investment, stakeholder rights and business performance. This is called the brand strength index ( BSI), according to the report of Brand Finance, according to this standard, Roche is now the most powerful brand in the industry, with a brand strength index (BSI) score of 79.7 points, and the only brand in the ranking with an AAA rating.

According to the Brand Strength Index (BSI), the top five most powerful pharmaceutical brands in the world are Roche, Bayer, Bristol-Myers Squibb, Johnson & Johnson, Novo Nordisk.

Asian pharmaceutical brands enter the rankings for the first time

This year Brand Finance expanded its ranking from the top 10 to the top 25, and Asian pharmaceutical brands also appeared in the rankings for the first time. They are Sinopharm Group from China, Shanghai Pharmaceuticals and Takeda Pharmaceuticals headquartered in Japan. Sinopharm Group and Takeda Pharmaceuticals each have their own The brand value of USD 2 billion ranked 15th and 16th respectively, and Shanghai Pharmaceuticals ranked 24th.

Brand Finance believes that as a symbol of the rapid development of China's medical device industry, Sinopharm Group has acquired a 60% stake in China's scientific equipment company, integrated medical device distribution business, and expanded its influence in the industry.

Takeda Pharmaceutical, which ranked 16th, followed closely after the acquisition of Shire at the beginning of last year, quickly reshaping its brand, increasing its exposure in the United States, the world’s largest pharmaceutical market, and adding Shire’s lucrative drug portfolio to Takeda's product pipeline.

Moreover, Takeda Pharmaceuticals is now listed on the Tokyo and New York Stock Exchanges, and it can expand its global business through wider capital market access and providing longer trading time for global investors.